“The success of the SELECT-MDS-1 trial was as an efficiently accrued international phase 3 trial that was biomarker driven, the first of its kind in MDS. Although the doublet combination tested in ...

Biophytis SA (OTCPK:BPTSY) Tuesday unveiled its strategic outlook for the year and said that 2025 will be decisive for the company, with several major initiatives to accelerate the clinical ...

Opthea's Phase 3 COAST trial for wet AMD failed its primary endpoint, raising concerns about the company's financial stability. Opthea Limited announced that its global Phase 3 trial, COAST, ...

Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP ...

CEO Brian Lian highlighted 2024 as an exceptionally busy year, with successful results from four studies, including the Phase 2 VENTURE trial for subcutaneous VK2735, which demonstrated up to 14.7% ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of alternative endpoints in phase 3 oncology trials ...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan ...

A SpaceX Falcon 9 rocket in February 2024 launched six satellites for the Missile Defense Agency (MDA) and Space Development Agency (SDA). Credit: SpaceX COLORADO SPRINGS — The U.S. Space Force’s ...

The U.S. Space Force has issued a request for proposals to initiate the first on-ramp process to procure Lane 1 launch services as part of the National Security Space Launch program’s third phase.

Reviva Pharmaceuticals Holdings, Inc. announced that 446 participants have completed their long-term open-label extension (OLE) trial for brilaroxazine, with 156 participants receiving one year of ...

Neumora halted one trial of its depression drug navacaprant and paused a pair of late-stage studies as it tries to learn from a recent phase 3 failure. The KOASTAL-1 study, which read out in January, ...